ELITE PHARMACEUTICALS LONG TERM GOALS

# ELI-154 AND ELI-216 partnered, approved, and marketed in Europe and U.S.

# A branded product portfolio of Lodrane, Mikah product and others currently undisclosed

# A generic product portfolio using Elite's extended release and abuse resistant technologies

# Low cost generic manufacturing facility at Northvale, NJ producing 500 million to 1 billion tablets/capsules annually

# Strong sales partners (ECR, TAGI, Hi-Tech etc…) for generics

# Novel investment monetized

# NASDAQ listing